Global Cancer Biological Therapy Market By Product Type (Vaccines, Monoclonal Antibodies, and Cancer Growth Blockers), By Route of Administration (Oral and Injectable), By End-User (Hospitals & Clinics, Cancer Research Centres, and Laboratories), By Distribution Channel (Specialized Cancer Treatment Centers, Hospital Pharmacies, and Retail Pharmacies), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032
- Published date: Oct 2023
- Report ID: 66398
- Number of Pages: 346
- Format:
-
-
-
- Merck & Co., Inc.
- Hoffmann-La Roche Ltd
- Novartis AG Company Profile
- Amgen Inc.
- Bristol-Myers Squibb Company
- Celgene
- Eli Lilly and Company (US)
- EnGeneIC
- Pfizer Inc Company Profile
- Intas Pharmaceuticals Ltd.
- Astellas Pharma, Inc Company Profile
- Otsuka
- Teva Pharmaceutical Industries Ltd. Company Profile
- Bayer AG Company Profile
- GlaxoSmithKline PLC
- AbbVie Inc. Company Profile
- Astellas Pharma Inc.
- Seattle Genetics
- Takeda Pharmaceuticals
- Spectrum Pharmaceuticals
- Bausch Health Companies Inc.
- Johnson & Johnson Services, Inc.
- AstraZeneca Plc Company Profile
- Other Key Players
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible